A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders
NCT ID: NCT02802033
Last Updated: 2024-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
908 participants
OBSERVATIONAL
2016-01-31
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SpineTRACK Registry - Spinal Outcomes Registry
NCT01372592
OssDsign® Spine Registry Study ("Propel")
NCT05329129
Prospective Study of Minimally Invasive Spine Surgery
NCT01045473
Proprio Spine Measurement Tool
NCT07023393
Bone Graft Materials Observational Registry
NCT00974623
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Variables applicable to patients with a degenerative spine disorder which will be collected in the registry include:
* Patient details
* Symptoms
* Diagnosis
* Imaging assessment
* Treatment details
Feasibility phase:
The statistical evaluation of the feasibility and quality of data collection will be performed after the first 5 sites have each enrolled 12 patients with a degenerative pathology and documented one follow-up visit. During this evaluation, enrolment of further patients can be continued.
Based on the findings of this feasibility phase, adjustments to the existing database can be performed before the registry is rolled out on larger scale.
Registry expansion:
Following the evaluation process of the feasibility phase, the registry will be expanded to allow data entry in more sites globally. Multi-site participation of this registry will be rolled-out in stages, and will be offered to sites with appropriate expertise which are selected based on their potential (interest, resources and expected patient volume).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient diagnosed with a degenerative spine disorder who receives treatment for the degenerative spine disorder
* Patient capable of understanding the content of the patient information / Informed Consent Form
* Patient willing and able to participate in the registry
* Patient who has agreed to participate in the registry by providing consent according to the applicable local law and the declaration of Helsinki
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AO Foundation, AO Spine
OTHER
AO Innovation Translation Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tim Yoon, MD
Role: PRINCIPAL_INVESTIGATOR
Principal Coordinating Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
USC Spine Center, Keck Medical Center of USC
Los Angeles, California, United States
Emory University School of Medicine
Atlanta, Georgia, United States
The Johns Hopkins University
Baltimore, Maryland, United States
Mount Sinai Hospital
New York, New York, United States
New York Presbyterian - Columbia University Medical Center
New York, New York, United States
BG-Clinic Bergmannstrost
Halle, , Germany
Istituto Ortopedico Rizzoli
Bologna, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DegenPRO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.